United States Healthcare Equipment & Supplies

Repligen Corp (RGEN)

Track

Over the past 90 days, Repligen Corp has seen net insider selling totaling approximately $536,480. Key transactions involved executives, including the CEO and CFO, executing planned sales of company stock. These activities occurred following the company's May 2026 earnings report, which showed a 23.08% earnings per share beat, amid a 12.5% stock price increase over the last quarter.
Ticker: RGEN Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Repligen Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 16 Jul 2026
Value US$4,953,302.78 | Price 108.66 | Shares 32,511 (+28.0%)
Proposed sale 16 Jul 2026
Value US$943,970.33 | Price 465.43 | Shares 93,718
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-17 2026-07-16 PlS Planned sale
Garland Jason K

CFO

Officer
32,511 +28.0%
108.66
US$4,953,303 		32,511 +28.0% 108.66 US$4,953,303
2026-07-16 2026-07-16 PrS Proposed sale
Garland Jason K

Officer

Officer
93,718
465.43
US$943,970 		93,718 465.43 US$943,970
2026-06-26 2026-06-25 PlS Planned sale
Garland Jason K

CFO

Officer
62,054 -2.2%
75.89
US$899,152 		62,054 -2.2% 75.89 US$899,152
2026-06-25 2026-06-25 PrS Proposed sale
Garland Jason K

Officer

Officer
733
145.00
US$106,285 		733 145.00 US$106,285
2026-04-22 2026-04-21 S Sale
3.2
Loeillot Olivier

Chief Executive Officer

Executive Director
3,832 -6.6%
140.00
US$536,480 		3,832 -6.6% 140.00 US$536,480
2026-04-21 2026-04-21 PrS Proposed sale
3.2
Loeillot Olivier

Officer; Director

Executive Director
3,832
140.00
US$536,480 		3,832 140.00 US$536,480
2025-12-18 2025-12-17 S Sale
2.5
DAWES KAREN A
Non-Executive Director
275 -0.3%
161.00
US$44,275 		275 -0.3% 161.00 US$44,275
2025-12-17 2025-12-17 PrS Proposed sale
2.5
DAWES KAREN A

Director

Non-Executive Director
275
161.00
US$44,275 		275 161.00 US$44,275
2025-11-26 2025-11-25 S Sale
3.2
Loeillot Olivier

Chief Executive Officer

Executive Director
7,041 -16.4%
170.00
US$1,196,970 		7,041 -16.4% 170.00 US$1,196,970
2025-11-25 2025-11-25 PrS Proposed sale
3.2
Loeillot Olivier

Officer; Director

Executive Director
7,041
170.00
US$1,196,970 		7,041 170.00 US$1,196,970
2025-11-19 2025-11-18 S Sale
3.8
Bylund James

Chief Operating Officer

Officer
2,191 -9.2%
151.21
US$331,301 		2,191 -9.2% 151.21 US$331,301
2025-11-18 2025-11-18 PrS Proposed sale
3.8
Bylund James

Officer

Officer
2,191
151.21
US$331,304 		2,191 151.21 US$331,304
2025-11-14 2025-11-13 S Sale
3.2
Hunt Anthony
Non-Executive Director
1,956 -2.4%
157.11
US$307,307 		1,956 -2.4% 157.11 US$307,307
2025-11-14 2025-11-13 S Sale
3.2
Hunt Anthony
Non-Executive Director
5,737 -6.5%
156.22
US$896,234 		5,737 -6.5% 156.22 US$896,234
2025-11-14 2025-11-13 S Sale
3.2
Hunt Anthony
Non-Executive Director
3,000 -3.3%
155.45
US$466,350 		3,000 -3.3% 155.45 US$466,350
2025-11-14 2025-11-13 S Sale
3.2
Hunt Anthony
Non-Executive Director
2,500 -2.7%
154.32
US$385,800 		2,500 -2.7% 154.32 US$385,800
2025-11-14 2025-11-13 S Sale
3.2
Hunt Anthony
Non-Executive Director
2,923 -3.0%
153.14
US$447,628 		2,923 -3.0% 153.14 US$447,628
2025-11-14 2025-11-13 S Sale
3.2
Hunt Anthony
Non-Executive Director
2,100 -2.1%
152.17
US$319,557 		2,100 -2.1% 152.17 US$319,557
2025-11-14 2025-11-13 S Sale
3.2
Hunt Anthony
Non-Executive Director
1,784 -1.8%
151.01
US$269,402 		1,784 -1.8% 151.01 US$269,402
2025-11-13 2025-11-13 PrS Proposed sale
3.2
Hunt Anthony

Director

Non-Executive Director
20,000
154.62
US$3,092,327 		20,000 154.62 US$3,092,327
2025-11-13 2025-11-12 S Sale
3.2
Hunt Anthony
Non-Executive Director
464 -0.5%
158.51
US$73,549 		464 -0.5% 158.51 US$73,549
2025-11-13 2025-11-12 S Sale
3.2
Hunt Anthony
Non-Executive Director
11,096 -9.9%
158.01
US$1,753,279 		11,096 -9.9% 158.01 US$1,753,279
2025-11-13 2025-11-12 S Sale
3.2
Hunt Anthony
Non-Executive Director
4,959 -4.2%
156.65
US$776,827 		4,959 -4.2% 156.65 US$776,827
2025-11-13 2025-11-12 S Sale
3.2
Hunt Anthony
Non-Executive Director
4,740 -3.9%
155.85
US$738,729 		4,740 -3.9% 155.85 US$738,729
2025-11-13 2025-11-12 S Sale
3.2
Hunt Anthony
Non-Executive Director
3,741 -3.0%
154.92
US$579,556 		3,741 -3.0% 154.92 US$579,556
2025-11-12 2025-11-12 PrS Proposed sale
3.2
Hunt Anthony

Director

Non-Executive Director
25,000
156.88
US$3,921,981 		25,000 156.88 US$3,921,981
2025-09-11 2025-09-10 S Sale
3.2
Hunt Anthony
Non-Executive Director
2,179 -2.1%
122.23
US$266,339 		2,179 -2.1% 122.23 US$266,339
2025-09-11 2025-09-10 S Sale
3.2
Hunt Anthony
Non-Executive Director
7,584 -6.9%
121.42
US$920,849 		7,584 -6.9% 121.42 US$920,849
2025-09-11 2025-09-10 S Sale
3.2
Hunt Anthony
Non-Executive Director
14,882 -11.9%
120.19
US$1,788,668 		14,882 -11.9% 120.19 US$1,788,668
2025-09-11 2025-09-10 S Sale
3.2
Hunt Anthony
Non-Executive Director
3,262 -2.5%
119.64
US$390,266 		3,262 -2.5% 119.64 US$390,266
2025-09-11 2025-09-10 S Sale
3.2
Hunt Anthony
Non-Executive Director
1,108 -0.9%
118.32
US$131,099 		1,108 -0.9% 118.32 US$131,099
2025-09-11 2025-09-10 S Sale
3.2
Hunt Anthony
Non-Executive Director
96 -0.1%
116.34
US$11,169 		96 -0.1% 116.34 US$11,169
2025-09-10 2025-09-10 PrS Proposed sale
3.2
Hunt Anthony

Director

Non-Executive Director
29,111
120.52
US$3,508,378 		29,111 120.52 US$3,508,378
2025-08-12 2025-08-08 B Purchase
4.1
Madaus Martin D
Non-Executive Director
1,800 +inf%
112.13
US$201,830 		1,800 +inf% 112.13 US$201,830
2025-05-16 2025-05-15 S Sale
3.2
Hunt Anthony
Non-Executive Director
7 -0.0%
127.00
US$889 		7 -0.0% 127.00 US$889
2025-05-16 2025-05-15 S Sale
3.2
Hunt Anthony
Non-Executive Director
268 -0.2%
125.20
US$33,554 		268 -0.2% 125.20 US$33,554
2025-05-16 2025-05-15 S Sale
3.2
Hunt Anthony
Non-Executive Director
6,533 -5.6%
124.34
US$812,313 		6,533 -5.6% 124.34 US$812,313
2025-05-16 2025-05-15 S Sale
3.2
Hunt Anthony
Non-Executive Director
17,596 -13.1%
123.57
US$2,174,338 		17,596 -13.1% 123.57 US$2,174,338
2025-05-16 2025-05-15 S Sale
3.2
Hunt Anthony
Non-Executive Director
2,043 -1.5%
122.66
US$250,594 		2,043 -1.5% 122.66 US$250,594
2025-05-15 2025-05-15 PrS Proposed sale
3.2
Hunt Anthony

Director

Non-Executive Director
26,447
128.34
US$3,394,208 		26,447 128.34 US$3,394,208
2025-03-19 2025-03-17 S Sale
3.2
Hunt Anthony
Non-Executive Director
2,283 -1.6%
153.70
US$350,897 		2,283 -1.6% 153.70 US$350,897
2025-03-19 2025-03-17 S Sale
3.2
Hunt Anthony
Non-Executive Director
15,619 -10.1%
152.82
US$2,386,896 		15,619 -10.1% 152.82 US$2,386,896
2025-03-19 2025-03-17 S Sale
3.2
Hunt Anthony
Non-Executive Director
6,176 -3.9%
151.96
US$938,505 		6,176 -3.9% 151.96 US$938,505
2025-03-19 2025-03-17 S Sale
3.2
Hunt Anthony
Non-Executive Director
2,518 -1.5%
151.09
US$380,445 		2,518 -1.5% 151.09 US$380,445
2025-03-19 2025-03-17 S Sale
3.2
Hunt Anthony
Non-Executive Director
100 -0.1%
150.38
US$15,038 		100 -0.1% 150.38 US$15,038
2025-03-19 2025-03-17 S Sale
3.2
Hunt Anthony
Non-Executive Director
60 -0.0%
148.05
US$8,883 		60 -0.0% 148.05 US$8,883
2025-03-18 2025-03-17 B Purchase
0.7
Pax Margaret
Non-Executive Director
250 +31.5%
150.69
US$37,672 		250 +31.5% 150.69 US$37,672
2025-03-17 2025-03-17 PrS Proposed sale
3.2
Hunt Anthony

Director

Non-Executive Director
26,756
150.42
US$4,024,638 		26,756 150.42 US$4,024,638
2024-11-22 2024-11-21 S Sale
3.2
Hunt Anthony
Non-Executive Director
24,246 -14.8%
139.67
US$3,386,439 		24,246 -14.8% 139.67 US$3,386,439
2024-11-21 2024-11-21 PrS Proposed sale
3.2
Anthony Hunt

Executive Chairman
24,246
139.66
US$3,386,311 		24,246 139.66 US$3,386,311
2024-09-12 2024-09-10 S Sale
3.2
Hunt Anthony
Non-Executive Director
604 -0.4%
146.67
US$88,589 		604 -0.4% 146.67 US$88,589
2024-09-12 2024-09-10 S Sale
3.2
Hunt Anthony
Non-Executive Director
10,723 -7.1%
145.95
US$1,565,022 		10,723 -7.1% 145.95 US$1,565,022
2024-09-12 2024-09-10 S Sale
3.2
Hunt Anthony
Non-Executive Director
9,369 -5.8%
144.88
US$1,357,381 		9,369 -5.8% 144.88 US$1,357,381
2024-09-12 2024-09-10 S Sale
3.2
Hunt Anthony
Non-Executive Director
1,495 -0.9%
143.77
US$214,936 		1,495 -0.9% 143.77 US$214,936
2024-09-10 2024-09-10 PrS Proposed sale
3.2
Hunt Anthony

Officer

Officer
22,191
144.72
US$3,211,481 		22,191 144.72 US$3,211,481
2024-08-05 2024-08-02 S Sale
3.2
KURIYEL RALF

Senior VP, R&D

Officer
175 -1.4%
158.85
US$27,799 		175 -1.4% 158.85 US$27,799
2024-08-05 2024-08-02 S Sale
3.2
KURIYEL RALF

Senior VP, R&D

Officer
6,973 -36.2%
159.36
US$1,111,217 		6,973 -36.2% 159.36 US$1,111,217
2024-08-02 2024-08-02 PrS Proposed sale
3.2
Ralf Kuriyel

Senior Vice President
7,148
159.35
US$1,139,040 		7,148 159.35 US$1,139,040
2024-08-01 2024-08-01 PrS Proposed sale
3.0
Christine Gebski

Senior Vice President
2,160
167.00
US$360,720 		2,160 167.00 US$360,720
2024-08-01 2024-08-01 PrS Proposed sale
3.2
Ralf Kuriyel

Senior Vice President
4,465
165.67
US$739,705 		4,465 165.67 US$739,705
2024-08-01 2024-08-01 S Sale
3.2
KURIYEL RALF

Senior VP, R&D

Officer
4,465 -18.8%
165.67
US$739,717 		4,465 -18.8% 165.67 US$739,717
2024-06-14 2024-06-14 B Purchase
4.1
Madaus Martin D
Non-Executive Director
700 +17.9%
125.46
US$87,822 		700 +17.9% 125.46 US$87,822
2024-06-14 2024-06-14 B Purchase
4.1
Madaus Martin D
Non-Executive Director
915 +30.5%
124.54
US$113,954 		915 +30.5% 124.54 US$113,954
2024-06-14 2024-06-14 B Purchase
3.2
Hunt Anthony

Chief Executive Officer

Officer
2,000 +1.2%
124.08
US$248,160 		2,000 +1.2% 124.08 US$248,160
2024-06-14 2024-06-14 B Purchase
3.6
BARTHELEMY NICOLAS
Non-Executive Director
1,200 +34.6%
125.45
US$150,540 		1,200 +34.6% 125.45 US$150,540
2024-05-22 2024-05-21 S Sale
3.2
Hunt Anthony

Chief Executive Officer

Officer
969 -0.6%
171.03
US$165,728 		969 -0.6% 171.03 US$165,728
2024-05-22 2024-05-21 S Sale
3.2
Hunt Anthony

Chief Executive Officer

Officer
3,925 -2.3%
170.04
US$667,407 		3,925 -2.3% 170.04 US$667,407
2024-05-22 2024-05-21 S Sale
3.2
Hunt Anthony

Chief Executive Officer

Officer
2,963 -1.7%
169.27
US$501,547 		2,963 -1.7% 169.27 US$501,547
2024-05-22 2024-05-21 S Sale
3.2
Hunt Anthony

Chief Executive Officer

Officer
3,933 -2.2%
168.33
US$662,042 		3,933 -2.2% 168.33 US$662,042
2024-05-22 2024-05-21 S Sale
3.2
Hunt Anthony

Chief Executive Officer

Officer
4,008 -2.2%
167.05
US$669,536 		4,008 -2.2% 167.05 US$669,536
2024-05-22 2024-05-21 S Sale
3.2
Hunt Anthony

Chief Executive Officer

Officer
4,274 -2.3%
166.36
US$711,023 		4,274 -2.3% 166.36 US$711,023
2024-05-21 2024-05-21 PrS Proposed sale
3.2
Hunt Anthony

Officer

Officer
20,072
170.92
US$3,430,706 		20,072 170.92 US$3,430,706
2024-03-12 2024-03-11 S Sale
3.2
KURIYEL RALF

Senior VP, R&D

Officer
3,517 -12.7%
193.73
US$681,348 		3,517 -12.7% 193.73 US$681,348
2024-03-11 2024-03-11 PrS Proposed sale
3.2
Ralf Kuriyel

Officer

Officer
3,517
193.73
US$681,348 		3,517 193.73 US$681,348
2024-03-11 2024-03-08 S Sale
3.2
Hunt Anthony

Chief Executive Officer

Officer
156 -0.1%
202.55
US$31,598 		156 -0.1% 202.55 US$31,598
Explore more

More insider trading research around Repligen Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America